OklahomaHB 3834Oklahoma 2026 Regular SessionHouse

Ibogaine clinical trials; Oklahoma Breakthrough Therapy Act; terms; requirements for drug developers; contractual terms; intellectual property rights; reports; intellectual property account; effective date.

Sponsored By: Stan May (Republican)

In Committee

Senate Committee

Your PRIA Score

Score Hidden

Personalized for You

How does this bill affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & Cosponsors

Sponsor

  • Stan May

    Republican • House

Cosponsors

  • Avery Frix

    Republican • Senate

  • Daniel Pae

    Republican • House

Roll Call Votes

All Roll Calls

Yes: 83 • No: 25

Senate vote 4/22/2026

Top_of_Page

Yes: 0 • No: 0

Senate vote 4/13/2026

Top_of_Page

Yes: 0 • No: 2

House vote 3/11/2026

Top_of_Page

Yes: 68 • No: 23

House vote 2/19/2026

DO PASS

Yes: 10 • No: 0

House vote 2/11/2026

DO PASS

Yes: 5 • No: 0

Actions Timeline

  1. Reported Do Pass, amended by committee substitute Appropriations committee; CR filed

    4/22/2026Senate
  2. Referred to Appropriations

    4/13/2026Senate
  3. Reported Do Pass Health and Human Services committee; CR filed

    4/13/2026Senate
  4. Second Reading referred to Health and Human Services Committee then to Appropriations Committee

    4/1/2026Senate
  5. First Reading

    3/12/2026Senate
  6. Engrossed, signed, to Senate

    3/12/2026House
  7. Referred for engrossment

    3/11/2026House
  8. Third Reading, Measure passed: Ayes: 68 Nays: 23

    3/11/2026House
  9. Amended

    3/11/2026House
  10. General Order

    3/11/2026House
  11. CR; Do Pass Health and Human Services Oversight Committee

    2/19/2026House
  12. Authored by Senator Frix (principal Senate author)

    2/11/2026House
  13. Coauthored by Representative(s) Pae

    2/11/2026House
  14. Policy recommendation to the Health and Human Services Oversight committee; Do Pass Public Health

    2/11/2026House
  15. Referred to Public Health

    2/3/2026House
  16. Second Reading referred to Health and Human Services Oversight

    2/3/2026House
  17. Authored by Representative May

    2/2/2026House
  18. First Reading

    2/2/2026House

Bill Text

  • Floor (Senate)

    4/23/2026

  • Senate Committee Report 2

    4/22/2026

  • Senate Committee Substitute for House Bill

    4/22/2026

  • Senate Committee Report 1

    4/13/2026

  • Engrossed

    3/12/2026

  • Floor (House)

    2/20/2026

  • House Committee Report

    2/19/2026

  • House Policy Committee Report

    2/11/2026

  • Introduced

    1/15/2026

Related Bills

Back to State Legislation